0
     

Report Added
Report already added
Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity

Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity

Global single cell multiomics market will reach $14,369.5 million by 2031, growing by 18.6% annually over 2021-2031, driven by the rising prevalence of chronic diseases along with the aging population, the widespread product adoption for visualization and analysis, technological advancements along with the rising R&D investment, and the significant growth in the pharmaceutical industry especially personalized medication.
Highlighted with 89 tables and 109 figures, this 207-page report “Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global single cell multiomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global single cell multiomics market in every aspect of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Instruments
•Consumables
•Software

Based on Omics Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Single Cell Genomics (SCG)
•Single Cell Transcriptomics (SCT)
•Single Cell Proteomics (SCP)
•Single Cell Metabolomics (SCM)

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Clinical Research
oOncology
oCell Therapy
oImmunology
oNeurology
oCell Biology
oOther Types of Clinical Research
•Translation Research
•Synthetic Biology

By Sample Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Human Samples
oCancer Tissues
oStem Cells
oImmune Cells
oBrain Cells
oOther Human Samples
•Animal Samples
•Microbial Samples

By Workflow, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Single-Cell Isolation and Dispensing
oFluorescence-Activated Cell Sorting (FACS)
oMicrofluidics
oMagnetic-Activated Cell Sorting (MACS)
oRandom Seeding
oManual Cell Picking
oLaser Capture Microdissection
oOther Technologies of Single-Cell Isolation and Dispensing
•Single-Cell Analysis
oPolymerase Chain Reaction
oNext-Generation Sequencing
oMass Cytometry
oMass Spectrometry
oOther Technologies of Single-Cell Analysis

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Research and Academic Laboratories
•Biopharmaceutical and Biotech Companies
•Contract Research Organizations (CROs)
•Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:
•North America (U.S., Canada, and Mexico)
•Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
•APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
•South America (Brazil, Chile, Argentina, Rest of South America)
•MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Omics Type, Workflow and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
10x Genomics, Inc.
1CellBio, Inc.
Becton, Dickinson and Company
Berkeley Lights, Inc.
BGI Genomics Co., Ltd.
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
BioTuring, Inc.
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Fluidigm Corporation
Fluxion Biosciences
Illimina, Inc
Mission Bio, Inc.
Namocell, Inc.
NanoString Technologies, Inc.
Parse Biosciences, Inc.
Proteona
Qiagen N.V.
RareCyte, Inc.
Scipio Biosciences SAS
Shilps Sciences
Takara Bio Inc. (Takara Holdings)
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction11
1.1 Industry Definition and Research Scope11
1.1.1 Industry Definition11
1.1.2 Research Scope12
1.2 Research Methodology15
1.2.1 Overview of Market Research Methodology15
1.2.2 Market Assumption16
1.2.3 Secondary Data16
1.2.4 Primary Data16
1.2.5 Data Filtration and Model Design17
1.2.6 Market Size/Share Estimation18
1.2.7 Research Limitations19
1.3 Executive Summary20
2 Market Overview and Dynamics23
2.1 Market Size and Forecast23
2.1.1 Impact of COVID-19 on World Economy24
2.1.2 Impact of COVID-19 on the Market28
2.2 Major Growth Drivers30
2.3 Market Restraints and Challenges38
2.4 Emerging Opportunities and Market Trends41
2.5 Porter’s Fiver Forces Analysis45
3 Segmentation of Global Market by Product Type49
3.1 Market Overview by Product Type49
3.2 Instruments51
3.3 Consumables52
3.4 Software53
4 Segmentation of Global Market by Omics Type54
4.1 Market Overview by Omics Type54
4.2 Single Cell Genomics (SCG)56
4.3 Single Cell Transcriptomics (SCT)57
4.4 Single Cell Proteomics (SCP)58
4.5 Single Cell Metabolomics (SCM)59
5 Segmentation of Global Market by Application60
5.1 Market Overview by Application60
5.2 Clinical Research62
5.2.1 Oncology64
5.2.2 Cell Therapy65
5.2.3 Immunology66
5.2.4 Neurology67
5.2.5 Cell Biology68
5.2.6 Other Types of Clinical Research69
5.3 Translation Research70
5.4 Synthetic Biology71
6 Segmentation of Global Market by Sample Type72
6.1 Market Overview by Sample Type72
6.2 Human Samples74
6.2.1 Cancer Tissues76
6.2.2 Stem Cells77
6.2.3 Immune Cells78
6.2.4 Brain Cells79
6.2.5 Other Human Samples80
6.3 Animal Samples81
6.4 Microbial Samples82
7 Segmentation of Global Market by Workflow83
7.1 Market Overview by Workflow83
7.2 Single-Cell Isolation and Dispensing85
7.2.1 Fluorescence-Activated Cell Sorting (FACS)87
7.2.2 Microfluidics88
7.2.3 Magnetic-Activated Cell Sorting (MACS)89
7.2.4 Random Seeding90
7.2.5 Manual Cell Picking91
7.2.6 Laser Capture Microdissection92
7.2.7 Other Technologies of Single-Cell Isolation and Dispensing93
7.3 Single-Cell Analysis94
7.3.1 Polymerase Chain Reaction96
7.3.2 Next-Generation Sequencing97
7.3.3 Mass Cytometry98
7.3.4 Mass Spectrometry99
7.3.5 Other Technologies of Single-Cell Analysis100
8 Segmentation of Global Market by End User101
8.1 Market Overview by End User101
8.2 Research and Academic Laboratories103
8.3 Biopharmaceutical and Biotech Companies104
8.4 Contract Research Organizations (CROs)105
8.5 Other End Users106
9 Segmentation of Global Market by Region107
9.1 Geographic Market Overview 2021-2031107
9.2 North America Market 2021-2031 by Country111
9.2.1 Overview of North America Market111
9.2.2 U.S.115
9.2.3 Canada118
9.2.4 Mexico120
9.3 European Market 2021-2031 by Country122
9.3.1 Overview of European Market122
9.3.2 Germany126
9.3.3 U.K.128
9.3.4 France130
9.3.5 Spain132
9.3.6 Italy134
9.3.7 Netherlands136
9.3.8 Rest of European Market138
9.4 Asia-Pacific Market 2021-2031 by Country140
9.4.1 Overview of Asia-Pacific Market140
9.4.2 Japan144
9.4.3 China147
9.4.4 Australia149
9.4.5 India151
9.4.6 South Korea153
9.4.7 Rest of APAC Region155
9.5 South America Market 2021-2031 by Country157
9.5.1 Argentina160
9.5.2 Brazil162
9.5.3 Chile164
9.5.4 Rest of South America Market166
9.6 MEA Market 2021-2031 by Country167
9.6.1 UAE170
9.6.2 Saudi Arabia172
9.6.3 South Africa174
9.6.4 Other National Markets176
10 Competitive Landscape177
10.1 Overview of Key Vendors177
10.2 New Product Launch, Partnership, Investment, and M&A181
10.3 Company Profiles182
10x Genomics, Inc.182
1CellBio, Inc.184
Becton, Dickinson and Company185
Berkeley Lights, Inc.186
BGI Genomics Co., Ltd.187
Bio-Rad Laboratories, Inc.188
Bio-Techne Corporation189
BioTuring, Inc.190
Danaher Corporation (Cytiva Life Sciences)191
Dolomite Bio192
Fluidigm Corporation193
Fluxion Biosciences194
Illimina, Inc195
Mission Bio, Inc.196
Namocell, Inc.197
NanoString Technologies, Inc.198
Parse Biosciences, Inc.199
Proteona200
Qiagen N.V.201
RareCyte, Inc.202
Scipio Biosciences SAS203
Shilps Sciences204
Takara Bio Inc. (Takara Holdings)205
Thermo Fisher Scientific Inc.206
RELATED REPORTS207

List of Figures:

Figure 1. Research Method Flow Chart15
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation18
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-203120
Figure 4. Global Single Cell Multiomics Market, 2021-2031, $ mn23
Figure 5. Impact of COVID-19 on Business28
Figure 6. Primary Drivers and Impact Factors of Global Single Cell Multiomics Market30
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million33
Figure 8. Total Reported Cases of Lyme Disease by Year in U.S., 1998-201934
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million36
Figure 10. World Population 65 and Over, % of Total Population, 1950-206036
Figure 11. Primary Restraints and Impact Factors of Global Single Cell Multiomics Market38
Figure 12. Investment Opportunity Analysis42
Figure 13. Porter’s Fiver Forces Analysis of Global Single Cell Multiomics Market45
Figure 14. Breakdown of Global Single Cell Multiomics Market by Product Type, 2021-2031, % of Revenue50
Figure 15. Global Addressable Market Cap in 2022-2031 by Product Type, Value ($ mn) and Share (%)50
Figure 16. Global Single Cell Multiomics Market by Product Type: Instruments, 2021-2031, $ mn51
Figure 17. Global Single Cell Multiomics Market by Product Type: Consumables, 2021-2031, $ mn52
Figure 18. Global Single Cell Multiomics Market by Product Type: Software, 2021-2031, $ mn53
Figure 19. Breakdown of Global Single Cell Multiomics Market by Omics Type, 2021-2031, % of Sales Revenue55
Figure 20. Global Addressable Market Cap in 2022-2031 by Omics Type, Value ($ mn) and Share (%)55
Figure 21. Global Single Cell Multiomics Market by Omics Type: Single Cell Genomics (SCG), 2021-2031, $ mn56
Figure 22. Global Single Cell Multiomics Market by Omics Type: Single Cell Transcriptomics (SCT), 2021-2031, $ mn57
Figure 23. Global Single Cell Multiomics Market by Omics Type: Single Cell Proteomics (SCP), 2021-2031, $ mn58
Figure 24. Global Single Cell Multiomics Market by Omics Type: Single Cell Metabolomics (SCM), 2021-2031, $ mn59
Figure 25. Breakdown of Global Single Cell Multiomics Market by Application, 2021-2031, % of Sales Revenue61
Figure 26. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)61
Figure 27. Global Single Cell Multiomics Market by Application: Clinical Research, 2021-2031, $ mn62
Figure 28. Global Single Cell Multiomics Market by Clinical Research: Oncology, 2021-2031, $ mn64
Figure 29. Global Single Cell Multiomics Market by Clinical Research: Cell Therapy, 2021-2031, $ mn65
Figure 30. Global Single Cell Multiomics Market by Clinical Research: Immunology, 2021-2031, $ mn66
Figure 31. Global Single Cell Multiomics Market by Clinical Research: Neurology, 2021-2031, $ mn67
Figure 32. Global Single Cell Multiomics Market by Clinical Research: Cell Biology, 2021-2031, $ mn68
Figure 33. Global Single Cell Multiomics Market by Clinical Research: Other Types of Clinical Research, 2021-2031, $ mn69
Figure 34. Global Single Cell Multiomics Market by Application: Translation Research, 2021-2031, $ mn70
Figure 35. Global Single Cell Multiomics Market by Application: Synthetic Biology, 2021-2031, $ mn71
Figure 36. Breakdown of Global Single Cell Multiomics Market by Sample Type, 2021-2031, % of Revenue73
Figure 37. Global Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%)73
Figure 38. Global Single Cell Multiomics Market by Sample Type: Human Samples, 2021-2031, $ mn74
Figure 39. Global Single Cell Multiomics Market by Human Samples: Cancer Tissues, 2021-2031, $ mn76
Figure 40. Global Single Cell Multiomics Market by Human Samples: Stem Cells, 2021-2031, $ mn77
Figure 41. Global Single Cell Multiomics Market by Human Samples: Immune Cells, 2021-2031, $ mn78
Figure 42. Global Single Cell Multiomics Market by Human Samples: Brain Cells, 2021-2031, $ mn79
Figure 43. Global Single Cell Multiomics Market by Human Samples: Other Human Samples, 2021-2031, $ mn80
Figure 44. Global Single Cell Multiomics Market by Sample Type: Animal Samples, 2021-2031, $ mn81
Figure 45. Global Single Cell Multiomics Market by Sample Type: Microbial Samples, 2021-2031, $ mn82
Figure 46. Breakdown of Global Single Cell Multiomics Market by Workflow, 2021-2031, % of Revenue84
Figure 47. Global Addressable Market Cap in 2022-2031 by Workflow, Value ($ mn) and Share (%)84
Figure 48. Global Single Cell Multiomics Market by Workflow: Single-Cell Isolation and Dispensing, 2021-2031, $ mn85
Figure 49. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Fluorescence-Activated Cell Sorting (FACS), 2021-2031, $ mn87
Figure 50. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Microfluidics, 2021-2031, $ mn88
Figure 51. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Magnetic-Activated Cell Sorting (MACS), 2021-2031, $ mn89
Figure 52. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Random Seeding, 2021-2031, $ mn90
Figure 53. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Manual Cell Picking, 2021-2031, $ mn91
Figure 54. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Laser Capture Microdissection, 2021-2031, $ mn92
Figure 55. Global Single Cell Multiomics Market by Single-Cell Isolation and Dispensing: Other Technologies of Single-Cell Isolation and Dispensing, 2021-2031, $ mn93
Figure 56. Global Single Cell Multiomics Market by Workflow: Single-Cell Analysis, 2021-2031, $ mn94
Figure 57. Global Single Cell Multiomics Market by Single-Cell Analysis: Polymerase Chain Reaction, 2021-2031, $ mn96
Figure 58. Global Single Cell Multiomics Market by Single-Cell Analysis: Next-Generation Sequencing, 2021-2031, $ mn97
Figure 59. Global Single Cell Multiomics Market by Single-Cell Analysis: Mass Cytometry, 2021-2031, $ mn98
Figure 60. Global Single Cell Multiomics Market by Single-Cell Analysis: Mass Spectrometry, 2021-2031, $ mn99
Figure 61. Global Single Cell Multiomics Market by Single-Cell Analysis: Other Technologies of Single-Cell Analysis, 2021-2031, $ mn100
Figure 62. Breakdown of Global Single Cell Multiomics Market by End User, 2021-2031, % of Revenue101
Figure 63. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)102
Figure 64. Global Single Cell Multiomics Market by End User: Research and Academic Laboratories, 2021-2031, $ mn103
Figure 65. Global Single Cell Multiomics Market by End User: Biopharmaceutical and Biotech Companies, 2021-2031, $ mn104
Figure 66. Global Single Cell Multiomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn105
Figure 67. Global Single Cell Multiomics Market by End User: Other End Users, 2021-2031, $ mn106
Figure 68. Global Market Snapshot by Region107
Figure 69. Geographic Spread of Worldwide Single Cell Multiomics Market, 2021-2031, % of Sales Revenue108
Figure 70. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%)109
Figure 71. North American Single Cell Multiomics Market, 2021-2031, $ mn112
Figure 72. Breakdown of North America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue113
Figure 73. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)114
Figure 74. U.S. Single Cell Multiomics Market, 2021-2031, $ mn116
Figure 75. Canada Single Cell Multiomics Market, 2021-2031, $ mn118
Figure 76. Single Cell Multiomics Market in Mexico, 2021-2031, $ mn120
Figure 77. European Single Cell Multiomics Market, 2021-2031, $ mn123
Figure 78. Breakdown of European Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue124
Figure 79. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)125
Figure 80. Single Cell Multiomics Market in Germany, 2021-2031, $ mn126
Figure 81. Single Cell Multiomics Market in U.K., 2021-2031, $ mn128
Figure 82. Single Cell Multiomics Market in France, 2021-2031, $ mn130
Figure 83. Single Cell Multiomics Market in Spain, 2021-2031, $ mn132
Figure 84. Single Cell Multiomics Market in Italy, 2021-2031, $ mn134
Figure 85. Single Cell Multiomics Market in Netherlands, 2021-2031, $ mn136
Figure 86. Single Cell Multiomics Market in Rest of Europe, 2021-2031, $ mn138
Figure 87. Asia-Pacific Single Cell Multiomics Market, 2021-2031, $ mn141
Figure 88. Breakdown of APAC Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue141
Figure 89. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)143
Figure 90. Single Cell Multiomics Market in Japan, 2021-2031, $ mn145
Figure 91. Single Cell Multiomics Market in China, 2021-2031, $ mn147
Figure 92. Single Cell Multiomics Market in Australia, 2021-2031, $ mn149
Figure 93. Single Cell Multiomics Market in India, 2021-2031, $ mn151
Figure 94. Single Cell Multiomics Market in South Korea, 2021-2031, $ mn153
Figure 95. Single Cell Multiomics Market in Rest of APAC, 2021-2031, $ mn155
Figure 96. South America Single Cell Multiomics Market, 2021-2031, $ mn158
Figure 97. Breakdown of South America Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue158
Figure 98. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)159
Figure 99. Single Cell Multiomics Market in Argentina, 2021-2031, $ mn160
Figure 100. Single Cell Multiomics Market in Brazil, 2021-2031, $ mn162
Figure 101. Single Cell Multiomics Market in Chile, 2021-2031, $ mn164
Figure 102. Single Cell Multiomics Market in Rest of South America, 2021-2031, $ mn166
Figure 103. Single Cell Multiomics Market in Middle East and Africa (MEA), 2021-2031, $ mn168
Figure 104. Breakdown of MEA Single Cell Multiomics Market by Country, 2021 and 2031, % of Revenue168
Figure 105. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)169
Figure 106. Single Cell Multiomics Market in UAE, 2021-2031, $ mn170
Figure 107. Single Cell Multiomics Market in Saudi Arabia, 2021-2031, $ mn172
Figure 108. Single Cell Multiomics Market in South Africa, 2021-2031, $ mn174
Figure 109. Growth Stage of Global Single Cell Multiomics Industry over the Forecast Period177

Report Title: Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW